The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses

Recently, we have shown that the administration of the tumour-targeted antibody-based immunocytokine L19-IL2 after radiotherapy (RT) resulted in synergistic anti-tumour effect. Here we show that RT and L19-IL2 can activate a curative abscopal effect, with a long-lasting immunological memory. Ionizin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncoimmunology
Päätekijät: Rekers, Nicolle H., Olivo Pimentel, Veronica, Yaromina, Ala, Lieuwes, Natasja G., Biemans, Rianne, Zegers, Catharina M. L., Germeraad, Wilfred T. V., Van Limbergen, Evert J., Neri, Dario, Dubois, Ludwig J., Lambin, Philippe
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2018
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889197/
https://ncbi.nlm.nih.gov/pubmed/29632732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1414119
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia